Latest KFF Health News Stories
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
Estadounidenses van a México a comprar insulina por un costo mucho más bajo
Millones cruzan la frontera para tratamientos y para comprar medicinas. La pregunta es si es una práctica legal. En Utah establecen turismo médico.
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
¿Pueden los estados reparar el desastre que es el sistema de salud?
La legalización del matrimonio gay comenzó en algunos estados y se convirtió en una ley nacional. La marihuana parece seguir la misma ruta. ¿Podría ser el caso de la reforma sanitaria?
Analysis: Can States Fix The Disaster Of American Health Care?
The governor of California has proposed some big ideas. Who knows whether he can pull them off, but there’s reason for hope.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Extreme Temperatures May Pose Risks To Some Mail-Order Meds
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
